ImmunoGen preclinical data

IMGN said that C242-DM1, the murine version of its huC242-DM1/SB-408075 humanized monoclonal antibody combined with the maytansinoid toxin DM1, gave complete tumor regression for 28-92 days and 84 days in mouse models of pancreatic and non-small cell lung cancer, respectively. Data were presented at the Molecular Targets and Cancer Therapeutics conference in Washington. ...